Xu Y - Search Results

1

Phase I/II Clinical Study of PRaG Regimen Combined With Intraperitoneal Infusion of PD-1 Inhibitor for Advanced Refractory Solid Tumors With Cancerous Ascites (PRaG4.0P Study).

Xu Y, Kong Y, Ma Y, Xu M, Yang J, Zhang J, Chen R, Chen G, Hong Z, Zhao X, Zhang C, Xing P, Zhang L, Zhao P. Xu Y, et al. Among authors: xu m. Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241264169. doi: 10.1177/15330338241264169. Technol Cancer Res Treat. 2024. PMID: 39051686 Free PMC article. Clinical Trial.

2

Comparative effectiveness of two different doses of botulinum toxin A for the treatment of mild to moderate depression.

Shu H, Shen T, Deng W, Cao J, Xu Y, Liu J, Zhou X, Luo WF. Shu H, et al. Among authors: xu y. J Affect Disord. 2024 Apr 1;350:824-830. doi: 10.1016/j.jad.2024.01.158. Epub 2024 Jan 19. J Affect Disord. 2024. PMID: 38246284

3

The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.

Zou L, Liu FH, Shen PP, Hu Y, Liu XQ, Xu YY, Pen QL, Wang B, Zhu YQ, Tian Y. Zou L, et al. Among authors: xu yy. Breast Cancer. 2018 May;25(3):309-314. doi: 10.1007/s12282-018-0830-3. Epub 2018 Feb 3. Breast Cancer. 2018. PMID: 29397555

4

Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia.

Liu J, Xu YY, Zhang QL, Luo WF. Liu J, et al. Pain Res Manag. 2018 Apr 5;2018:7365148. doi: 10.1155/2018/7365148. eCollection 2018. Pain Res Manag. 2018. PMID: 29849847 Free PMC article.

5

Effects of Different Etiologies of Anterior Circulation Tandem Lesions on Short-term Prognosis of Acute Ischemic Stroke.

Huang Z, Xu Y, You S, Guo Z, Xu J, Cao Y, Xiao G, Liu CF. Huang Z, et al. Among authors: xu y, xu j. Curr Neurovasc Res. 2023;20(1):70-75. doi: 10.2174/1567202620666230201121411. Curr Neurovasc Res. 2023. PMID: 36725823

6

Evaluation of therapeutic benefits of botulinum toxin for foot dystonia associated with Parkinson's disease.

Ni P, Xu YY, Wang LN, Cao JQ, Luo WF, Zhang QL, Li X, Zhou XP, Liu J. Ni P, et al. Toxicon. 2024 Feb 1;238:107587. doi: 10.1016/j.toxicon.2023.107587. Epub 2023 Dec 22. Toxicon. 2024. PMID: 38142904

7

Vitamin D and focal brain atrophy in PD with non-dementia: a VBM study.

Xu Y, Wang E, Zhang Q, Liu J, Luo W. Xu Y, et al. Front Hum Neurosci. 2024 Nov 29;18:1474148. doi: 10.3389/fnhum.2024.1474148. eCollection 2024. Front Hum Neurosci. 2024. PMID: 39677405 Free PMC article.

8

The safety and efficacy of botulinum toxin A on the treatment of depression.

Zhang Q, Wu W, Fan Y, Li Y, Liu J, Xu Y, Jiang C, Tang Z, Cao C, Liu T, Chen LH, Hu H, Luo W. Zhang Q, et al. Among authors: xu y. Brain Behav. 2021 Sep;11(9):e2333. doi: 10.1002/brb3.2333. Epub 2021 Aug 22. Brain Behav. 2021. PMID: 34423572 Free PMC article.

9

Association analyses between the variants of SNAP25, SV2C and ST3GAL2 and the efficacy of botulinum toxin A in the treatment of the primary Meige syndrome.

Wu WQ, Li K, Chu LL, Shen TT, Li Y, Xu YY, Zhang QL, Liu CF, Liu J, Zhou XP, Luo WF. Wu WQ, et al. Among authors: xu yy. Heliyon. 2024 Mar 31;10(8):e28543. doi: 10.1016/j.heliyon.2024.e28543. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38628704 Free PMC article.

10

Diagnostic value of 18F-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis.

Zheng M, Xie D, Pan C, Xu Y, Yu W. Zheng M, et al. Among authors: xu y. Nucl Med Commun. 2018 Jun;39(6):479-485. doi: 10.1097/MNM.0000000000000839. Nucl Med Commun. 2018. PMID: 29634659 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,254 results

Search Page

Filters